Clinical trial Recruiting at 1 site Interventional Ages 5 to 7

Buzzy Bee for Pain and Anxiety Control During Pediatric Dental Local Anesthesia

Official title: Effectiveness of Buzzy Bee Device in Anxiety Reduction and Pain Control During Local Anesthesia Administration

Run by Tanta University · NCT07886333 · Data updated 2026-11-12

This study tests whether the Buzzy Bee device, with cold and vibration, reduces pain and anxiety during a dental injection in kids aged 5-7 compared with standard distraction.

More Anxiety trials

Quick facts

Study typeInterventional
Ages5 Years to 7 Years
SexAll
Enrollment40 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta)
StatusRecruiting
StartedAugust 1, 2025
Main results expectedOctober 2026
Study endsNovember 2026
Registry record updatedOctober 26, 2026
Trial IDNCT07886333 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 5-7 who are ASA-I, cooperative (Frankl 3-4), require bilateral maxillary buccal infiltration across at least two visits, and have no neurological or psychological disorders.

Probably not a fit

Children with low cooperation (Frankl 1-2), neurological or psychological disorders, acute dental pain at the injection site, or allergies to local anesthetics may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized crossover trial, 40 healthy children aged 5-7 will receive two maxillary buccal infiltrations, one with the Buzzy Bee device and one with a conventional technique, across two visits separated by one week. Each visit uses topical lidocaine, followed by 4% articaine with epinephrine, with outcome measures including heart rate and pain scores (FLACC and Wong-Baker). The order of interventions is AB or BA, and a crossover design allows each child to serve as their own control. The study aims to determine if Buzzy Bee can reduce physiological arousal and reported pain during local anesthesia in pediatric patients. Primary setting is the Outpatient Clinic of the Pediatric Dentistry Department, Faculty of Dentistry, Tanta University, with ASA-I healthy children and cooperative behavior required.

Why it matters

Potential benefit: If successful, the Buzzy Bee approach could lessen pain and anxiety during dental injections, improving cooperation and reducing avoidance of future dental care.

How similar studies have gone: Prior studies in pediatric dentistry have explored vibration and distraction for pain relief; results are mixed but supportive of non-pharmacologic aids in reducing discomfort.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Systemically healthy children classified as ASA-I.
* Children requiring bilateral maxillary buccal infiltration local anesthesia across at least two separate dental treatment appointments.
* Co-operative child with a Frankl behavior rating of 3,4.
* Children free from any neurological or psychological disorder.

Exclusion Criteria:

* Children with known allergy to local anesthetic agents.
* Children with developmental delays, intellectual disabilities, or severe uncooperative behavior (Frankl rating 1 or 2).
* Children presenting with acute dental pain, swelling, or active infection at the injection site.
* Parental refusal to provide written informed consent for participation

Where it's running

  • faculty of dentistry, Tanta university
    Tanta, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.